Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1969 1
1973 2
1985 1
1986 5
1987 5
1988 2
1989 2
1990 2
1991 1
1995 1
1996 1
1997 1
2002 1
2005 1
2006 2
2007 6
2008 3
2010 1
2011 2
2012 2
2014 1
2017 2
2018 1
2019 3
2020 3
2021 5
2022 1
2023 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer.
Ragoonanan D, Khazal SJ, Abdel-Azim H, McCall D, Cuglievan B, Tambaro FP, Ahmad AH, Rowan CM, Gutierrez C, Schadler K, Li S, Di Nardo M, Chi L, Gulbis AM, Shoberu B, Mireles ME, McArthur J, Kapoor N, Miller J, Fitzgerald JC, Tewari P, Petropoulos D, Gill JB, Duncan CN, Lehmann LE, Hingorani S, Angelo JR, Swinford RD, Steiner ME, Hernandez Tejada FN, Martin PL, Auletta J, Choi SW, Bajwa R, Dailey Garnes N, Kebriaei P, Rezvani K, Wierda WG, Neelapu SS, Shpall EJ, Corbacioglu S, Mahadeo KM. Ragoonanan D, et al. Among authors: gill jb. Nat Rev Clin Oncol. 2021 Jul;18(7):435-453. doi: 10.1038/s41571-021-00474-4. Epub 2021 Feb 19. Nat Rev Clin Oncol. 2021. PMID: 33608690 Free PMC article. Review.
Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2.
Ragoonanan D, Khazal SJ, Mejia R, Ewing L, Durand JB, Bashoura L, Tayar J, Dailey Garnes N, Petropoulos D, Tewari P, Bhatti M, Ahmad AH, Cortes J, Razvi S, McBeth K, Swinford R, Shoberu B, Waseemuddin W, Chi L, Gill JB, Zaky W, Daw N, Gutierrez C, Tereffe W, Kebriaei P, Rezvani K, Shpall EJ, Champlin RE, Mahadeo KM. Ragoonanan D, et al. Among authors: gill jb. Front Oncol. 2021 Feb 4;11:625707. doi: 10.3389/fonc.2021.625707. eCollection 2021. Front Oncol. 2021. PMID: 33614514 Free PMC article. Review.
The meningococcal carrier-rate.
Fraser PK, Bailey GK, Abbott JD, Gill JB, Walker DJ. Fraser PK, et al. Among authors: gill jb. Lancet. 1973 Jun 2;1(7814):1235-7. doi: 10.1016/s0140-6736(73)90541-2. Lancet. 1973. PMID: 4122576 No abstract available.
Corrective osteotomies in spine surgery.
Gill JB, Levin A, Burd T, Longley M. Gill JB, et al. J Bone Joint Surg Am. 2008 Nov;90(11):2509-20. doi: 10.2106/JBJS.H.00081. J Bone Joint Surg Am. 2008. PMID: 18978421 Review.
Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium.
Hingorani P, Zhang W, Zhang Z, Xu Z, Wang WL, Roth ME, Wang Y, Gill JB, Harrison DJ, Teicher BA, Erickson SW, Gatto G, Kolb EA, Smith MA, Kurmasheva RT, Houghton PJ, Gorlick R. Hingorani P, et al. Among authors: gill jb. Mol Cancer Ther. 2022 Aug 2;21(8):1318-1325. doi: 10.1158/1535-7163.MCT-21-0758. Mol Cancer Ther. 2022. PMID: 35657346
ABBV-085, Antibody-Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium.
Hingorani P, Roth ME, Wang Y, Zhang W, Gill JB, Harrison DJ, Teicher B, Erickson S, Gatto G, Smith MA, Kolb EA, Gorlick R. Hingorani P, et al. Among authors: gill jb. Mol Cancer Ther. 2021 Mar;20(3):535-540. doi: 10.1158/1535-7163.MCT-20-0406. Epub 2020 Dec 9. Mol Cancer Ther. 2021. PMID: 33298592 Free PMC article.
59 results